益盛药业：拟使用不超过5000万元人民币的闲置自有资金购买理财产品

Group 1 - Yisheng Pharmaceutical announced plans to use up to 50 million RMB of idle funds to purchase financial products to improve capital efficiency while ensuring operational needs and fund safety [1] - The funds can be used on a rolling basis within a maximum period of 12 months [1] - As of the report date, Yisheng Pharmaceutical has a market capitalization of 2.7 billion RMB [1] Group 2 - For the first half of 2025, Yisheng Pharmaceutical's revenue composition is as follows: 81.06% from the pharmaceutical industry, 10.27% from health products and others, 7.39% from cosmetics, and 1.28% from other sources [1]